BioRestorative Therapies Inc

BioRestorative Therapies Inc

BRTX

Get informed when a big investor buys or sells

+ Follow
Market Cap$4.3M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
BioRestorative Therapies IncBioRestorative Therapies Inc-0.4--365%--
$-0.44

Current Fair Value

228.4% downside

Overvalued by 228.4% based on the discounted cash flow analysis.

Share Statistics

Market cap$4.30 Million
Enterprise Value$1.19 Million
Dividend Yield$- (-)
Earnings per Share$-1.58
Beta0.2
Outstanding Shares8,993,115

Return

Return on Equity-365.43%ROE
Return on Assets-238.27%
Return on Invested Capital-471.90%

Valuation & Multiples

P/E Ratio-0.39P/E Ratio
PEG0.65PEG
Price to Sales-Price to Sales
Price to Book Ratio-Price to Book Ratio
Enterprise Value to Revenue3.31
Enterprise Value to EBIT-0.08
Enterprise Value to Net Income-1
Total Debt to Enterprise0
Debt to Equity0Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
May 14, 2026
EPS Estimate
$-0.30
Average shareholder expectation
Revenue Estimate
$312,500
Average shareholder expectation

Next Earnings Call

Expected Date
August 11, 2026
EPS Estimate
$-0.15
Average shareholder expectation
Revenue Estimate
$335,000
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio0.00000%
Total Calls-
Total Puts-

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %7.53%▲ 3.94%
Total Invested$184,219▼ 51.95%
Investors Holding10▼ 3.00%

ESG Score

No data

About BioRestorative Therapies Inc

5 employees
CEO: Mark Weinreb